Abstract
Background: Animal-derived surfactants contain different chemical compositions with various responses, efficacy and safety profiles in treating preterm infants with respiratory distress syndrome. The study aimed to compare the safety and efficacy between poractant alfa (Curosurf®) and beractant (Survanta®) in preterm infants requiring endotracheal surfactant therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
